Table of Contents
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Radiofrequency Catheters Overview 6
3 Products under Development 7
3.1 Radiofrequency Catheters – Pipeline Products by Stage of Development 7
3.2 Radiofrequency Catheters – Pipeline Products by Territory 8
3.3 Radiofrequency Catheters – Pipeline Products by Regulatory Path 9
3.4 Radiofrequency Catheters – Pipeline Products by Estimated Approval Date 10
3.5 Radiofrequency Catheters – Ongoing Clinical Trials 11
4 Radiofrequency Catheters – Pipeline Products under Development by Companies 12
4.1 Radiofrequency Catheters Companies – Pipeline Products by Stage of Development 12
4.2 Radiofrequency Catheters – Pipeline Products by Stage of Development 13
5 Radiofrequency Catheters Companies and Product Overview 14
5.1 Handok Inc Company Overview 14
5.1.1 Handok Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Handok-Kalos Medical Company Overview 16
5.2.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 17
5.3.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Mayo Clinic Company Overview 18
5.4.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Medtronic plc Company Overview 19
5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 MicroPort Scientific Corp Company Overview 27
5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Renal Dynamics, LLC Company Overview 28
5.7.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 St. Jude Medical LLC Company Overview 29
5.8.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Suzhou SyMap Medical Ltd Company Overview 30
5.9.1 Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Verve Medical, Inc. Company Overview 33
5.10.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
6 Radiofrequency Catheters- Recent Developments 34
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 34
6.2 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 36
6.3 Sep 20, 2019: Terumo to increase production capacity for alliance business 37
6.4 Aug 28, 2019: Medtronic announces planned leadership succession 37
6.5 Aug 20, 2019: Medtronic reports first quarter financial results for 2019 39
6.6 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 42
6.7 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility 42
6.8 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results 43
6.9 May 22, 2019: Results announced from two Renal Denervation Studies at EuroPCR show positive outcomes in high-risk hypertensive patients 45
6.10 May 21, 2019: Terumo appoints EU based Subsidiary’s Associate as the Newest Terumo Fellow 46
6.11 Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai 47
6.12 Feb 26, 2019: Terumo to construct new facilities at its Vietnamese factory -15 billion yen investment to strengthen interventional therapeutic related production 48
6.13 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 48
7 Appendix 50
7.1 Methodology 50
7.2 About GlobalData 53
7.3 Contact Us 53
7.4 Disclaimer 53
Table 1: Radiofrequency Catheters - Pipeline Products by Stage of Development
Table 2: Radiofrequency Catheters - Pipeline Products by Territory
Table 3: Radiofrequency Catheters - Pipeline Products by Regulatory Path
Table 4: Radiofrequency Catheters - Pipeline Products by Estimated Approval Date
Table 5: Radiofrequency Catheters - Ongoing Clinical Trials
Table 6: Radiofrequency Catheters Companies - Pipeline Products by Stage of Development
Table 7: Radiofrequency Catheters - Pipeline Products by Stage of Development
Table 8: Handok Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: 2nd Gen Renal Denervation System - Product Status
Table 10: 2nd Gen Renal Denervation System - Product Description
Table 11: 3rd Gen Renal Denervation System - Product Status
Table 12: 3rd Gen Renal Denervation System - Product Description
Table 13: Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 14: DENEX - Product Status
Table 15: DENEX - Product Description
Table 16: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Renal Denervation Catheter - Product Status
Table 18: Renal Denervation Catheter - Product Description
Table 19: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Pressure Wire - Product Status
Table 21: Pressure Wire - Product Description
Table 22: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Symplicity Renal Denervation System - Product Status
Table 24: Symplicity Renal Denervation System - Product Description
Table 25: Symplicity Spyral Renal Denervation Catheter - Product Status
Table 26: Symplicity Spyral Renal Denervation Catheter - Product Description
Table 27: Medtronic plc - Ongoing Clinical Trials Overview
Table 28: Symplicity Renal Denervation System - A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients with Chronic Heart Failure (CHF)
Table 29: Symplicity Renal Denervation System - Global Prospective Registry for Sympathetic Renal Denervation in Selected Indications Through 3 Years Registry
Table 30: Symplicity Renal Denervation System - Renal Denervation in Treatment Resistant Hypertension
Table 31: Symplicity Renal Denervation System - Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients with Hypertensive Heart Disease: A Pilot Study
Table 32: Symplicity Renal Denervation System - Understanding the Mechanisms of Progressive Decrease in Blood Pressure after Renal Nerve Ablation
Table 33: Symplicity Spyral Renal Denervation Catheter - A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients with Therapy Resistant Arterial Hypertension with Large Renal Arteries
Table 34: Symplicity Spyral Renal Denervation Catheter - Combined Treatment with Percutaneous Coronary Intervention and Renal Denervation in Hypertensive Patients with Acute Coronary Syndromes
Table 35: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED)
Table 36: Symplicity Spyral Renal Denervation Catheter - Global Clinical Study of Renal Denervation with the Symplicity Spyral Multi-electrode Renal Denervation System in Patients with Uncontrolled Hypertension on Standard Medical Therapy: SPYRAL HTN-ON MED
Table 37: Symplicity Spyral Renal Denervation Catheter - Renal Nerve Denervation in Patients with Hypertension and Paroxysmal and Persistent Atrial Fibrillation
Table 38: Symplicity Spyral Renal Denervation Catheter - Symplicity Spyral Renal Denervation Study for High Blood Pressure Patients Prescribed Anti-hypertensive Medication
Table 39: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 40: FlashPoint Renal Artery RF Ablation Catheter - Product Status
Table 41: FlashPoint Renal Artery RF Ablation Catheter - Product Description
Table 42: Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 43: ReDy Renal Denervation System - Product Status
Table 44: ReDy Renal Denervation System - Product Description
Table 45: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Third Generation EnligHTN Renal Denervation System - Product Status
Table 47: Third Generation EnligHTN Renal Denervation System - Product Description
Table 48: Suzhou SyMap Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 49: SyMapCath I Catheter - Product Status
Table 50: SyMapCath I Catheter - Product Description
Table 51: Suzhou SyMap Medical Ltd - Ongoing Clinical Trials Overview
Table 52: SyMapCath I Catheter - A Prospective, Multicenter, Blind, Randomized and Controlled Trial of Selected Renal Denervation by Renal Nerve Mapping for the Treatment of Hypertension (HTN) in the Absence of Antihypertensive Medications (OFF MED)
Table 53: SyMapCath I Catheter - A Prospective, Multicenter, Single Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath I Catheter and SYMPIONEER S1 Stimulator/Generator for the Treatment of Hypertension (SMART Trial)
Table 54: Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Verve Medical System - Product Status
Table 56: Verve Medical System - Product Description
Table 57: Glossary
List of Figures
Figure 1: Radiofrequency Catheters - Pipeline Products by Stage of Development
Figure 2: Radiofrequency Catheters - Pipeline Products by Territory
Figure 3: Radiofrequency Catheters - Pipeline Products by Regulatory Path
Figure 4: Radiofrequency Catheters - Pipeline Products by Estimated Approval Date
Figure 5: Radiofrequency Catheters - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer